Primary Melanoma of the Lung Treated with Surgery, Dabrafenib and Trametinib

Abstract

This is a case report on a 69-year-old woman who was diagnosed with malignant melanoma presenting in the lung. A complete staging workup was performed by her oncologist, with no skin lesion identified as a primary. CT-guided needle biopsy of the lung nodule was completed, with pathology revealing atypical cells consistent with malignant melanoma. Following full body examination by the cutaneous oncologist, a robotic wedge resection and lymph node dissection accompanied by bronchoscopy were performed. Molecular testing (Caris Life Sciences) of the surgical tumor specimen revealed pathological <i>BRAF</i> DNA mutation in <i>exon 15</i>/<i>p.V600K</i>. The patient was initially treated with nivolumab, then treated with a combination of dabrafenib and trametinib at recurrence.